Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Search by expertise, name or affiliation
Fragile X mental retardation protein: Past, present and future
Miri Kim,
Stephanie Ceman
Beckman Institute for Advanced Science and Technology
Cell and Developmental Biology
Carl R. Woese Institute for Genomic Biology
Biomedical and Translational Sciences
Neuroscience Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fragile X mental retardation protein: Past, present and future'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Fragile X Syndrome
100%
Fragile X Mental Retardation Protein
100%
Futures Past
100%
Past-present
100%
Post-translational Modification
33%
Glutamatergic Neurotransmission
33%
Progenitor Cells
33%
Neuronal Phenotype
33%
Metabotropic Glutamate Receptor
33%
Trinucleotide Repeats
33%
Novel Therapeutics
33%
Fragile X Mental Retardation 1 (FMR1)
33%
Premutation
33%
Patient Phenotype
33%
Domain-specific Features
33%
Biochemistry, Genetics and Molecular Biology
Posttranslational Modification
100%
Glutamate Receptor
100%
Progenitor Cell
100%
Trinucleotide Repeat Expansion
100%
Glutamatergic
100%
FMR1
100%
Premutation
100%